F16.121
Hallucinogen abuse with intoxication with delirium
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F16.121 refers to a specific mental health condition that involves the abuse of hallucinogenic substances accompanied by intoxication and delirium. This condition highlights the complex effects that certain drugs can have on mental and physical health, often leading to significant disruptions in daily functioning. Recognizing the signs, causes, and potential consequences is essential for those affected and their support systems.
Causes & Symptoms
Clinical Causes: Use of hallucinogenic drugs such as LSD, psilocybin (magic mushrooms), DMT, mescaline, or synthetic hallucinogens Repeated substance use leading to dependency and misuse Underlying mental health issues or psychological conditions Peer pressure and social environment encouraging drug experimentation Accessibility and availability of hallucinogens in certain communities
Key Symptoms: Altered perception of reality, including visual or auditory hallucinations Confusion and disorientation Rapid mood swings or emotional instability Anxiety, paranoia, or panic attacks Physical symptoms such as increased heart rate, sweating, and dilated pupils Delirium characterized by agitation, inability to focus, and fluctuating levels of consciousness Impaired judgment and risky behavior
Diagnostic & Treatment
Diagnosis Path: The diagnosis typically involves a detailed clinical assessment that considers medical history, substance use patterns, and the presence of symptoms. Healthcare providers may perform physical examinations, laboratory tests (such as blood or urine screens), and mental health evaluations to confirm the presence of intoxication and delirium linked to hallucinogen use.
Treatment Protocols: Treatment approaches focus on managing acute symptoms and supporting recovery. Intervention strategies may include: - Medical stabilization to address physical symptoms like agitation or cardiovascular effects - Monitoring and managing delirium symptoms in a controlled environment - Psychosocial interventions such as counseling and behavioral therapies - Education about the risks of hallucinogen abuse and relapse prevention - Long-term addiction treatment programs for sustained recovery It's important to seek professional help when substance abuse and intoxication symptoms are evident, as untreated conditions can lead to severe health complications.
Clinical Advice & FAQs
Billing Guidance
Is F16.121 a billable ICD-10 code?
Yes, F16.121 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F16.121?
Clinical documentation must specify the nature of Hallucinogen abuse with intoxication with delirium and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
